Back
ESC Premium Access

The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude.

Session: Poster session 6 - Chronic heart failure (CHF)
Topic: Cardiotoxicity of drugs
Speaker: Mr C. Schneider (Graz, AT)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Mr Christopher Schneider

Graz (Austria)
0 follower

28 more presentations in this session

Cardiac remote organ response in multiple myeloma

Speaker: Doctor A. Cho (Vienna, AT)

Access
Abstract
Like
Thumbnail

Influence of sympathetic nerve activity on prognostic impact of hyperuricemia in patients with heart failure.

Speaker: Associate Professor S. Joho (Toyama, JP)

Access
Abstract
Like
Thumbnail

Role of pathophysiological cardiac substrate on prognosis of ambulatory patients with chronic heart failure

Speaker: Mr E. Sole Gonzalez (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

Three-dimensional speckle tracking echocardiography identifies subclinical dysfunction of left ventricle on long-term lymphoma survivors: a case-control study

Speaker: Doctor L. Cheng (Shanghai, CN)

Access
Abstract
Like
Thumbnail

The increased challenge of elderly people diagnosed with cancer, do we know their real basal cardiovascular reserve?

Speaker: Associate Professor A. Martin Garcia (Salamanca, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 6 - Chronic heart failure (CHF)

Speakers: Mr C. Schneider, Doctor A. Cho, Associate Professor S. Joho, Mr E. Sole Gonzalez, Doctor L. Cheng...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources